These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39083926)

  • 1. Alterations in intratumoral and peripheral immune status in recurrent gliomas and their prognostic implications for patients underwent reoperation.
    Ou A; Hu W; Jiang P; Lu J; Zheng Y; Ke C; Mou Y; Sai K; Li D
    Int Immunopharmacol; 2024 Oct; 140():112797. PubMed ID: 39083926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Preoperative Systemic Cellular Inflammatory Markers in Gliomas: A Systematic Review and Meta-Analysis.
    Wang DP; Kang K; Lin Q; Hai J
    Clin Transl Sci; 2020 Jan; 13(1):179-188. PubMed ID: 31550075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
    Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
    Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the immune gene expression signature associated with recurrence of high-grade gliomas.
    Roura AJ; Gielniewski B; Pilanc P; Szadkowska P; Maleszewska M; Krol SK; Czepko R; Kaspera W; Wojtas B; Kaminska B
    J Mol Med (Berl); 2021 Feb; 99(2):241-255. PubMed ID: 33215304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of DOK3 indicates high suppressive immune cell infiltration and unfavorable prognosis of gliomas.
    Liu X; Chen F; Li W
    Int Immunopharmacol; 2020 Jun; 83():106400. PubMed ID: 32193105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma.
    Fu W; Wang W; Li H; Jiao Y; Huo R; Yan Z; Wang J; Wang S; Wang J; Chen D; Cao Y; Zhao J
    Front Immunol; 2020; 11():835. PubMed ID: 32457755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.
    Zhou J; Pei X; Yang Y; Wang Z; Gao W; Ye R; Zhang X; Liu J; Liu Z; Yang X; Tao J; Gu C; Hu W; Chan FL; Li X; Mao J; Wu D
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Biomarker in Patients with Low-Grade Gliomas.
    Tan Z; Shen L; Wu H; Deng L; Li Z; Huang X
    World Neurosurg; 2019 Dec; 132():e585-e590. PubMed ID: 31442642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of inflammation markers in postoperative gliomas with or without adjuvant treatments.
    Luo Y; Deng R; Zhong Q; Luo D; Li X; Chen X; Tao S; Feng Z; Jiayi L; Huang Y; Li J; Liu W
    Medicine (Baltimore); 2021 Jun; 100(25):e26437. PubMed ID: 34160435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ratio of intratumoral CD15
    Watanabe J; Kimura T; Saze Z; Sato N; Kofunato Y; Ishigame T; Okada R; Kenjo A; Kono K; Marubashi S
    Cancer Rep (Hoboken); 2024 Jun; 7(6):e2099. PubMed ID: 38837676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of DC-SIGN
    Hu B; Wang Z; Zeng H; Qi Y; Chen Y; Wang T; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
    Cancer Res; 2020 Apr; 80(8):1707-1719. PubMed ID: 32060149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Stress Exacerbates the Immunosuppressive Microenvironment and Progression of Gliomas by Reducing Secretion of CCL3.
    Wang X; Zhang L; Zhou Y; Wang Y; Wang X; Zhang Y; Quan A; Mao Y; Zhang Y; Qi J; Ren Z; Gu L; Yu R; Zhou X
    Cancer Immunol Res; 2024 May; 12(5):516-529. PubMed ID: 38437646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased infiltration of CD8 T cells in recurrent glioblastoma patients is a useful biomarker for assessing the response to combined bevacizumab and lomustine therapy.
    Lin P; Jiang H; Zhao YJ; Pang JS; Liao W; He Y; Lin ZY; Yang H
    Int Immunopharmacol; 2021 Aug; 97():107826. PubMed ID: 34091114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma.
    Kim SW; Kim YI; Mustafa B; Kim MJ; Jeong G; Ahn SM; Lim SB; Yu CS; Kim JC; Hong SM; Park IJ
    Mod Pathol; 2021 Jan; 34(1):141-160. PubMed ID: 32709987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLEC7A regulates M2 macrophages to suppress the immune microenvironment and implies poorer prognosis of glioma.
    Wang J; Li X; Wang K; Li K; Gao Y; Xu J; Peng R; Zhang X; Zhang S; Zhou Y; Xu S; Zhang J
    Front Immunol; 2024; 15():1361351. PubMed ID: 38846954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune microenvironment of gliomas.
    Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
    Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas.
    Zhang Y; Xie Y; He L; Tang J; He Q; Cao Q; Cui L; Guo W; Hua K; Dimberg A; Wang L; Zhang L
    Cell Oncol (Dordr); 2021 Feb; 44(1):193-204. PubMed ID: 32915415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological classification of gliomas based on immunogenomic profiling.
    Feng Q; Li L; Li M; Wang X
    J Neuroinflammation; 2020 Nov; 17(1):360. PubMed ID: 33246490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct tumor-TAM interactions in IDH-stratified glioma microenvironments unveiled by single-cell and spatial transcriptomics.
    Motevasseli M; Darvishi M; Khoshnevisan A; Zeinalizadeh M; Saffar H; Bayat S; Najafi A; Abbaspour MJ; Mamivand A; Olson SB; Tabrizi M
    Acta Neuropathol Commun; 2024 Aug; 12(1):133. PubMed ID: 39148129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and local immunosuppression in glioblastoma and its prognostic significance.
    Stepanenko AA; Sosnovtseva AO; Valikhov MP; Chernysheva AA; Abramova OV; Pavlov KA; Chekhonin VP
    Front Immunol; 2024; 15():1326753. PubMed ID: 38481999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.